At a glance
- Germany is the world’s second largest donor to international health and development programs, after the United States.
- We invest heavily in efforts by the German government and German nongovernmental organizations, companies, and research institutions to improve the lives of people in the world’s poorest nations.
- German-led efforts that we support range from soil health programs in Ethiopia to mRNA vaccine development by biotechnology companies BioNTech and CureVac.
Germany has a deep commitment to reducing global inequity and is the world’s second largest donor to international health and development programs, after the United States. We invest heavily in efforts by nongovernmental organizations, companies, universities, and research institutions across Germany to improve the lives of people in the world’s poorest nations.
Our collaborations with German partners include a Grand Challenges Partnership with the German Federal Ministry of Education and Research (BMBF) and the African Academy of Sciences to support African scientists who are pursuing innovations in maternal, newborn, and child health.
Other recent investments also include support for Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), the German development agency, in its efforts to strengthen health insurance programs in India and soil health programs in Ethiopia; and support for tuberculosis drug candidate development by the Hamburg-based biotech company Evotec.
More about our work in Germany
Our office in Berlin supports our work with grantees and partners, builds and sustains European donor support, and helps foster political commitment in Europe to advance global health and development goals.